Longitudinal analysis of quality of life following treatment with Asunercept plus reirradiation versus reirradiation in progressive glioblastoma patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7373
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Longitudinal analysis of quality of life following treatment with Asunercept plus reirradiation versus reirradiation in progressive glioblastoma patients ; volume:145 ; number:3 ; day:2 ; month:11 ; year:2019 ; pages:531-540 ; date:12.2019
Journal of neuro-oncology ; 145, Heft 3 (2.11.2019), 531-540, 12.2019
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11060-019-03320-x
- URN
-
urn:nbn:de:101:1-2020032300021417139811
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wick, Wolfgang
- Krendyukov, Andriy
- Junge, Klaus
- Höger, Thomas
- Fricke, Harald
- SpringerLink (Online service)
Other Objects (12)
Nachweis eines metastasierungsassoziierten putativen Tumorsuppressorgens auf dem humanen Chromosom 15q
Molekulare Mechanismen von Migration und Invasion maligner Gliome
Current status and recent advances in reirradiation of glioblastoma
Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years’ experience of a single center
Re-irradiation: new frontiers
Re-irradiation for recurrent glioblastoma: a pattern of care analysis
Comparison of carbon ion and photon reirradiation for recurrent glioblastoma
Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies
Alectinib als Behandungsstrategie in Anaplastic lymphoma kinase-exprimierenden Glioblastomzellen : Biomarker des Inhibitors, Wirkmechanismus und Resistenzentstehung
Adjuvant re-irradiation vs. no early re-irradiation of resected recurrent glioblastoma: pooled comparative cohort analysis from two tertiary centers
Hyperfractionated abdominal reirradiation for gastrointestinal malignancies
FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?
Nachweis eines metastasierungsassoziierten putativen Tumorsuppressorgens auf dem humanen Chromosom 15q
Molekulare Mechanismen von Migration und Invasion maligner Gliome
Current status and recent advances in reirradiation of glioblastoma
Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years’ experience of a single center
Re-irradiation: new frontiers
Re-irradiation for recurrent glioblastoma: a pattern of care analysis
Comparison of carbon ion and photon reirradiation for recurrent glioblastoma
Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies
Alectinib als Behandungsstrategie in Anaplastic lymphoma kinase-exprimierenden Glioblastomzellen : Biomarker des Inhibitors, Wirkmechanismus und Resistenzentstehung
Adjuvant re-irradiation vs. no early re-irradiation of resected recurrent glioblastoma: pooled comparative cohort analysis from two tertiary centers
Hyperfractionated abdominal reirradiation for gastrointestinal malignancies
FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?
Nachweis eines metastasierungsassoziierten putativen Tumorsuppressorgens auf dem humanen Chromosom 15q
Molekulare Mechanismen von Migration und Invasion maligner Gliome
Current status and recent advances in reirradiation of glioblastoma
Hypofractionated stereotactic re-irradiation for progressive glioblastoma: twelve years’ experience of a single center
Re-irradiation: new frontiers
Re-irradiation for recurrent glioblastoma: a pattern of care analysis
Comparison of carbon ion and photon reirradiation for recurrent glioblastoma
Diagnostic biomarkers from proteomic characterization of cerebrospinal fluid in patients with brain malignancies
Alectinib als Behandungsstrategie in Anaplastic lymphoma kinase-exprimierenden Glioblastomzellen : Biomarker des Inhibitors, Wirkmechanismus und Resistenzentstehung
Adjuvant re-irradiation vs. no early re-irradiation of resected recurrent glioblastoma: pooled comparative cohort analysis from two tertiary centers
Hyperfractionated abdominal reirradiation for gastrointestinal malignancies